The fifth Symposium on Infectious Disease in the Immunocompromised Host convened in Seattle last month. Experts and rising ...

Fred Hutch Cancer Center aims to enroll 200,000 patients over the next 10 years in a new research program called TakePART-NW ...

Fred Hutch announces eight recipients of the 2025 Dr. Eddie Méndez Scholar Award, which honors exceptional postdoctoral researchers in the areas of cancer, infectious disease and basic science.

Dr. Mazyar Shadman is a blood cancer specialist who focuses on lymphoid malignancies. He is involved in clinical research using novel therapeutic agents for lymphoma and chronic lymphocytic leukemia, ...

The Atlas of Inspiring Hispanic/Latinx Scientists is a grassroots effort developed to showcase the expertise, talents, and diversity of Hispanic and Latinx scientific faculty. Featured scientists were ...

To get a copy of your medical records from Fred Hutch Cancer Center for yourself or someone else, complete a Release of Information Authorization/Medical Records ...

It was used ceremonially for centuries, but these days tobacco — now manufactured into highly addictive, commercial cigarettes — has become a scourge for many Indigenous people. “Since the early 1980s ...

Much has been written about the bumper crop of weight-loss drugs approved in the U.S. over the last several years. Advocates of the new pills and injections say they’ll help you attain your dream ...

Looking for information on Pediatric Bone Marrow Transplants? With our Cancer Consortium partners at Seattle Children’s, we also specialize in pediatric BMTs. Learn more about Pediatric BMT Blood and ...

Most cancer patients know that chemotherapy weakens their immune systems, putting them at risk for viral and bacterial infections. A month or two after chemo ends, however, most people assume their ...

Up to 90% of colorectal cancers can be cured if they are found early. But once cancer spreads outside the colon, it is much harder to treat. That’s why regular colorectal cancer screenings, starting ...

Dr. Christina Termini received her PhD in Biomedical Sciences from the University of New Mexico where she studied the spatiotemporal kinetics of acute myeloid leukemia signaling. She performed her ...